ReviewFrontiers in immunology2025
Experimental animal models of acute respiratory distress syndrome: one-hit and two-hit establishment application.
Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Broad-Spectrum Protective Effects of Lyophilized FE002-Lu Lung Fibroblast Conditioned Medium Against Acute and Chronic Pulmonary Injury in Wistar Rats.Biomedicines · 2026Article
- Positive end-expiratory pressure increases intracranial pressure but does not affect PRx, regardless of body position, in a porcine ARDS model.Frontiers in physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute respiratory distress syndrome (ARDS) is a complex syndrome with multiple risk factors that can lead to acute respiratory failure and, in turn, high morbidity and mortality. To clarify the syndrome's underlying pathomechanisms and develop novel therapies, we have summarized and analyzed a series of chief cause-induced animal models of ARDS. Aim: Although various animal models have been developed to represent the traits of human ARDS based on clinical symptoms and the yardstick of positive clinical trials, each model has unique features that reflect only part of the characteristics modeled. In response, this review aims to investigate characteristics of ARDS in current animal models and offers new strategies and insights for developing animal models aimed at capturing the features of human ARDS. Conclusion: This review summarizes the physiological characteristics of animals used in models of ARDS and evaluates the advantages and disadvantages of the chief cause-induced models for modeling human ARDS in animals, for results that can inform the establishment, assessment, and experimental study of ARDS in animal models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.